Population
Patients with or at risk for Adenovirus infections, including young children, healthy adults in crowded…
Design
Review
Authors
Loading...
Alerts clinicians to high mortality in immunocompromised adenovirus patients; leaves open definitive trials for cidofovir and vaccines.
Adenovirus infections present a significant risk to immunocompromised individuals and military recruits, with cidofovir serving as the primary treatment for severe cases and live oral vaccines providing effective prevention in military settings.
Kajon et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: